Is Armata Pharmaceuticals, Inc. ARMP stock halal to invest in?

No, as of August 2026, Armata Pharmaceuticals, Inc. stock (ARMP) is not currently classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. To qualify as halal under this standard, a company must keep non-permissible income below 5% of total revenue, keep both interest-bearing investments and interest-bearing debt below 30% of market capitalisation, and have no impermissible preference share structure. Armata Pharmaceuticals, Inc. currently does not meet the threshold for the non-permissible income and interest-bearing debt screens. Because screenings are refreshed monthly as new financial reports are published, a non-compliant stock can regain compliant status if its financial structure changes. You can track the latest status of Armata Pharmaceuticals, Inc. and discover Shariah compliant alternatives among the halal stocks in the Tabadulat app.

How often is Armata Pharmaceuticals, Inc. ARMP reviewed for Shariah compliance?

Tabadulat reviews Armata Pharmaceuticals, Inc. ARMP for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for Armata Pharmaceuticals, Inc. reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Non Permissible Income criteria?

No, as of August 2026, Armata Pharmaceuticals, Inc. stock (ARMP) does not pass the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. Armata Pharmaceuticals, Inc.'s income from non-permissible sources currently exceeds this 5% ceiling, which makes the stock non-compliant on this criterion regardless of how it performs on the other screens. The screen is reassessed monthly, so the status can change when the company releases new financial statements.

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of August 2026, Armata Pharmaceuticals, Inc. stock (ARMP) passes the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. This limit ensures shareholders are not materially profiting from riba (interest). Armata Pharmaceuticals, Inc.'s interest-bearing investments are currently within the 30% threshold. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Interest Bearing Debt criteria?

No, as of August 2026, Armata Pharmaceuticals, Inc. stock (ARMP) does not pass the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. Armata Pharmaceuticals, Inc.'s interest-bearing debt currently exceeds this 30% limit, meaning the company relies on riba-based financing beyond the level AAOIFI permits for a halal investment. A company can return to compliance by reducing debt or through changes in market capitalisation, and the screen is reassessed monthly.

What is the dividend purification factor for Armata Pharmaceuticals, Inc. ARMP stock?

Armata Pharmaceuticals, Inc. (ARMP) is currently classified as not Shariah compliant, so no dividend purification factor applies, because purification factors are calculated only for stocks that pass the AAOIFI screens. Purification (tazkiyah) is the practice of donating to charity the small portion of dividend income that stems from incidental non-permissible sources, such as interest earned on a compliant company's cash deposits. For non-compliant stocks the issue is not purification but eligibility: under AAOIFI Shariah Standard No. 21 the stock does not currently qualify as a halal investment. If Armata Pharmaceuticals, Inc. returns to compliance in a future monthly screening, its purification factor will be published alongside its updated status in the Tabadulat app.

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Preference Share screen?

Yes, as of August 2026, Armata Pharmaceuticals, Inc. stock (ARMP) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. Armata Pharmaceuticals, Inc. has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

Armata Pharmaceuticals, Inc.

NYSE

Shariah-Compliant

Not Shariah

ARMP

About

Armata Pharmaceuticals, Inc.

ARMP

Armata Pharmaceuticals Inc. is a biotechnology company dedicated to the development of innovative therapies to treat antibiotic-resistant infections. Operating in the healthcare sector, the company focuses on bacteriophage-based solutions, aiming to address the growing global issue of antimicrobial resistance. Armata Pharmaceuticals specializes in researching and developing treatments derived from natural phages, viruses that specifically target and eliminate bacteria, offering an alternative to traditional antibiotics. The company’s efforts are crucial in fields impacted by resistant bacterial strains, including healthcare-associated infections and chronic illnesses linked to bacterial biofilms. With its headquarters in the United States, Armata engages in collaborations with various research institutions and industry partners, emphasizing a scientific approach alongside cutting-edge technology. Armata Pharmaceuticals holds a significant position in the biopharmaceutical market, contributing to the advancement of precision medicine and public health innovations. Its dedication to addressing unmet medical needs positions it as a key player in the development of next-generation antimicrobial therapies. By exploring bacteriophage technology, Armata aims to provide targeted, effective alternatives that could revolutionize how infections are managed globally.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

Website:

https://www.armatapharma.com

ARMP

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Armata Pharmaceuticals, Inc.

About

Armata Pharmaceuticals, Inc.

ARMP

Frequently asked questions

Is Armata Pharmaceuticals, Inc. ARMP stock halal to invest in?

How often is Armata Pharmaceuticals, Inc. ARMP reviewed for Shariah compliance?

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Non Permissible Income criteria?

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Interest Bearing Investments criteria?

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for Armata Pharmaceuticals, Inc. ARMP stock?

Does Armata Pharmaceuticals, Inc. ARMP pass the AAOIFI Preference Share screen?

Can I buy Armata Pharmaceuticals (ARMP) stock on Tabadulat?

Open your account.

Deposit.

Screen.